ID   ASIC2_RAT               Reviewed;         512 AA.
AC   Q62962; O55163;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   02-OCT-2024, entry version 170.
DE   RecName: Full=Acid-sensing ion channel 2;
DE            Short=ASIC2;
DE   AltName: Full=Amiloride-sensitive brain sodium channel;
DE   AltName: Full=Amiloride-sensitive brain sodium channel 2;
DE   AltName: Full=Amiloride-sensitive cation channel 1, neuronal;
DE   AltName: Full=Amiloride-sensitive cation channel neuronal 1;
DE   AltName: Full=Brain sodium channel 1;
DE            Short=BNC1;
DE            Short=BNaC1;
DE   AltName: Full=Mammalian degenerin homolog {ECO:0000303|PubMed:8631835};
DE            Short=MDEG {ECO:0000303|PubMed:8631835};
GN   Name=Asic2; Synonyms=Accn1, Bnac1, Mdeg;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, MUTAGENESIS OF
RP   GLY-430 AND SER-443, AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=8631835; DOI=10.1074/jbc.271.18.10433;
RA   Waldmann R., Champigny G., Voilley N., Lauritzen I., Lazdunski M.;
RT   "The mammalian degenerin MDEG, an amiloride-sensitive cation channel
RT   activated by mutations causing neurodegeneration in Caenorhabditis
RT   elegans.";
RL   J. Biol. Chem. 271:10433-10436(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY,
RP   OLIGOMERIZATION, AND INTERACTION WITH ASIC3.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=9368048; DOI=10.1074/jbc.272.47.29778;
RA   Lingueglia E., de Weille J.R., Bassilana F., Heurteaux C., Sakai H.,
RA   Waldmann R., Lazdunski M.;
RT   "A modulatory subunit of acid sensing ion channels in brain and dorsal root
RT   ganglion cells.";
RL   J. Biol. Chem. 272:29778-29783(1997).
RN   [3]
RP   TISSUE SPECIFICITY, INTERACTION WITH ASIC2, AND FUNCTION.
RX   PubMed=9360943; DOI=10.1074/jbc.272.46.28819;
RA   Bassilana F., Champigny G., Waldmann R., de Weille J.R., Heurteaux C.,
RA   Lazdunski M.;
RT   "The acid-sensitive ionic channel subunit ASIC and the mammalian degenerin
RT   MDEG form a heteromultimeric H+-gated Na+ channel with novel properties.";
RL   J. Biol. Chem. 272:28819-28822(1997).
RN   [4]
RP   MUTAGENESIS OF HIS-72; HIS-109; HIS-127; HIS-145; HIS-158; HIS-162;
RP   HIS-180; HIS-249; HIS-326; HIS-339 AND GLY-430, AND REGULATION BY PROTONS
RP   AND ZINC.
RX   PubMed=11457851; DOI=10.1074/jbc.m105208200;
RA   Baron A., Schaefer L., Lingueglia E., Champigny G., Lazdunski M.;
RT   "Zn2+ and H+ are coactivators of acid-sensing ion channels.";
RL   J. Biol. Chem. 276:35361-35367(2001).
RN   [5]
RP   INDUCTION, AND INHIBITION BY DRUGS.
RX   PubMed=11588175; DOI=10.1523/jneurosci.21-20-08026.2001;
RA   Voilley N., de Weille J.R., Mamet J., Lazdunski M.;
RT   "Nonsteroid anti-inflammatory drugs inhibit both the activity and the
RT   inflammation-induced expression of acid-sensing ion channels in
RT   nociceptors.";
RL   J. Neurosci. 21:8026-8033(2001).
RN   [6]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11842212; DOI=10.1073/pnas.042688199;
RA   Alvarez de la Rosa D., Zhang P., Shao D., White F., Canessa C.M.;
RT   "Functional implications of the localization and activity of acid-sensitive
RT   channels in rat peripheral nervous system.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:2326-2331(2002).
RN   [7]
RP   INTERACTION WITH ASIC3.
RX   PubMed=14976185; DOI=10.1074/jbc.m313078200;
RA   Deval E., Salinas M., Baron A., Lingueglia E., Lazdunski M.;
RT   "ASIC2b-dependent regulation of ASIC3, an essential acid-sensing ion
RT   channel subunit in sensory neurons via the partner protein PICK-1.";
RL   J. Biol. Chem. 279:19531-19539(2004).
RN   [8]
RP   GLYCOSYLATION AT ASN-365 AND ASN-392, MUTAGENESIS OF LYS-4; ASN-22; PRO-37;
RP   ARG-63; TYR-67; HIS-72; ALA-81; ASN-365; ASN-392; TYR-414;
RP   423-TYR--VAL-425; 453-TYR--TYR-455; ASN-478 AND ASN-487, AND TOPOLOGY.
RX   PubMed=15504740; DOI=10.1074/jbc.m411849200;
RA   Saugstad J.A., Roberts J.A., Dong J., Zeitouni S., Evans R.J.;
RT   "Analysis of the membrane topology of the acid-sensing ion channel 2a.";
RL   J. Biol. Chem. 279:55514-55519(2004).
RN   [9]
RP   FUNCTION, INTERACTION WITH STOM, AND SUBCELLULAR LOCATION.
RX   PubMed=22850675; DOI=10.1038/emboj.2012.203;
RA   Brand J., Smith E.S., Schwefel D., Lapatsina L., Poole K., Omerbasic D.,
RA   Kozlenkov A., Behlke J., Lewin G.R., Daumke O.;
RT   "A stomatin dimer modulates the activity of acid-sensing ion channels.";
RL   EMBO J. 31:3635-3646(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8 AND SER-11, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [11]
RP   INTERACTION WITH SNAKE VENOM MAMBALGIN-1 AND MAMBALGIN-2, AND SUBUNIT.
RC   TISSUE=Venom, and Venom gland;
RX   PubMed=23034652; DOI=10.1038/nature11494;
RA   Diochot S., Baron A., Salinas M., Douguet D., Scarzello S.,
RA   Dabert-Gay A.-S., Debayle D., Friend V., Alloui A., Lazdunski M.,
RA   Lingueglia E.;
RT   "Black mamba venom peptides target acid-sensing ion channels to abolish
RT   pain.";
RL   Nature 490:552-555(2012).
RN   [12]
RP   INTERACTION WITH MAMBALGIN-1; MAMBALGIN-2 AND MAMBALGIN-3, SUBUNIT, AND
RP   REVIEW.
RX   PubMed=23624383; DOI=10.1016/j.toxicon.2013.04.008;
RA   Baron A., Diochot S., Salinas M., Deval E., Noel J., Lingueglia E.;
RT   "Venom toxins in the exploration of molecular, physiological and
RT   pathophysiological functions of acid-sensing ion channels.";
RL   Toxicon 75:187-204(2013).
CC   -!- FUNCTION: Cation channel with high affinity for sodium, which is gated
CC       by extracellular protons and inhibited by the diuretic amiloride. Also
CC       permeable for Li(+) and K(+). Activation by an extracellular pH drop is
CC       followed by a rapid pH-independent inactivation. Heteromeric channel
CC       assembly seems to modulate channel properties.
CC       {ECO:0000269|PubMed:22850675, ECO:0000269|PubMed:8631835,
CC       ECO:0000269|PubMed:9360943}.
CC   -!- SUBUNIT: Homotrimer or heterotrimer with other ASIC proteins (By
CC       similarity). Interacts with PRKCABP (By similarity). Interacts with
CC       STOM; this regulates channel activity. Interacts with ASIC1. Isoform 2
CC       interacts with ASIC3. Heterotrimer of Asic1a-Asic2a interacts with the
CC       snake venom mambalgin-1, mambalgin-2 and mambalgin-3 (PubMed:23034652,
CC       PubMed:23624383). Heterotrimer of Asic1a-Asic2b interacts with the
CC       snake venom mambalgin-1 and mambalgin-2 (PubMed:23034652).
CC       {ECO:0000250, ECO:0000269|PubMed:14976185, ECO:0000269|PubMed:22850675,
CC       ECO:0000269|PubMed:9360943, ECO:0000269|PubMed:9368048}.
CC   -!- INTERACTION:
CC       Q62962-1; D4A100: Stoml3; NbExp=2; IntAct=EBI-15615798, EBI-15615743;
CC       Q62962-2; D4A100: Stoml3; NbExp=2; IntAct=EBI-15615759, EBI-15615743;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11842212,
CC       ECO:0000269|PubMed:22850675}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:11842212, ECO:0000269|PubMed:22850675}.
CC       Note=Localized at the plasma membrane of neurons, in the soma and
CC       punctated peripheral processes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Mdeg1 {ECO:0000303|PubMed:9368048}, Asic2a;
CC         IsoId=Q62962-1; Sequence=Displayed;
CC       Name=2; Synonyms=Mdeg2 {ECO:0000303|PubMed:9368048}, Asic2b;
CC         IsoId=Q62962-2; Sequence=VSP_015594, VSP_015595;
CC   -!- TISSUE SPECIFICITY: Expressed in sciatic nerve and dorsal root ganglion
CC       (DRG) (at protein level). Both isoforms display the same expression
CC       pattern except in DRG where isoform 2 is more abundantly expressed.
CC       Widely distributed throughout the brain. Highly expressed in the main
CC       olfactory bulb, neo- and allo-cortical regions, hippocampal formation,
CC       habenula, basolateral amygdaloid nuclei, and cerebellum. In the
CC       olfactory system, expressed in the glomerular cell layer, the internal
CC       granular layer, and the mitral and internal plexiform cell layers.
CC       Within the glomerular layer, restricted to the periglomerular cells. In
CC       the neocortex, strongly expressed in the large pyramidal neurons in all
CC       cortical layers as well as in the oligo-, astro-, or micro-glia cells.
CC       In the hippocampal formation, expressed in dentate granule cells and
CC       hilar neurons, as well as in pyramidal cells of CA1-CA3 subfields.
CC       Expressed in stratum oriens and radiatum of all subfields. Within the
CC       thalamus, expressed moderately in the medial and lateral habenula. In
CC       the cerebellar cortex expressed in Purkinje cells and granule cells.
CC       Expressed at low levels in choroid plexus.
CC       {ECO:0000269|PubMed:11842212, ECO:0000269|PubMed:8631835,
CC       ECO:0000269|PubMed:9360943, ECO:0000269|PubMed:9368048}.
CC   -!- DEVELOPMENTAL STAGE: Appears just before birth, reaches maximum levels
CC       after birth, then declines slightly until adulthood.
CC   -!- INDUCTION: Up-regulation upon tissues inflammation is abolished by
CC       anti-inflammatory drugs. {ECO:0000269|PubMed:11588175}.
CC   -!- MISCELLANEOUS: Regulated by Zn(2+). Inhibited by anti-inflammatory
CC       drugs like salicylic acid.
CC   -!- MISCELLANEOUS: [Isoform 2]: Seems to be inactive as monomer or in a
CC       monomeric assembly and is not activated by mutagenesis of Gly-430.
CC       Mutagenesis of Ser-60 into Gly reduces activation by PKC through
CC       PRKCABP/PICK-1 of a ASIC3/ACCN3-ASIC2/ASIC2b channel. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the amiloride-sensitive sodium channel (TC
CC       1.A.6) family. ASIC2 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U53211; AAC52588.1; -; mRNA.
DR   EMBL; Y14635; CAA74979.1; -; mRNA.
DR   RefSeq; NP_001029186.1; NM_001034014.1. [Q62962-1]
DR   RefSeq; NP_037024.2; NM_012892.2. [Q62962-2]
DR   AlphaFoldDB; Q62962; -.
DR   SMR; Q62962; -.
DR   DIP; DIP-41193N; -.
DR   IntAct; Q62962; 1.
DR   MINT; Q62962; -.
DR   STRING; 10116.ENSRNOP00000068763; -.
DR   ChEMBL; CHEMBL3562171; -.
DR   TCDB; 1.A.6.1.2; the epithelial na(+) channel (enac) family.
DR   GlyCosmos; Q62962; 2 sites, No reported glycans.
DR   GlyGen; Q62962; 2 sites.
DR   iPTMnet; Q62962; -.
DR   PhosphoSitePlus; Q62962; -.
DR   DNASU; 25364; -.
DR   Ensembl; ENSRNOT00000086961.2; ENSRNOP00000068763.2; ENSRNOG00000058308.2. [Q62962-2]
DR   Ensembl; ENSRNOT00000112270.1; ENSRNOP00000080191.1; ENSRNOG00000058308.2. [Q62962-1]
DR   GeneID; 25364; -.
DR   KEGG; rno:25364; -.
DR   AGR; RGD:2017; -.
DR   CTD; 40; -.
DR   RGD; 2017; Asic2.
DR   GeneTree; ENSGT00940000154991; -.
DR   InParanoid; Q62962; -.
DR   OMA; AMIRKGC; -.
DR   OrthoDB; 3415680at2759; -.
DR   PhylomeDB; Q62962; -.
DR   TreeFam; TF330663; -.
DR   Reactome; R-RNO-2672351; Stimuli-sensing channels.
DR   PRO; PR:Q62962; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   GO; GO:0043197; C:dendritic spine; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098839; C:postsynaptic density membrane; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0015280; F:ligand-gated sodium channel activity; ISO:RGD.
DR   GO; GO:0005261; F:monoatomic cation channel activity; ISO:RGD.
DR   GO; GO:0005216; F:monoatomic ion channel activity; IDA:RGD.
DR   GO; GO:0022839; F:monoatomic ion-gated channel activity; ISO:RGD.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IDA:RGD.
DR   GO; GO:0071468; P:cellular response to acidic pH; IDA:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IDA:RGD.
DR   GO; GO:0050974; P:detection of mechanical stimulus involved in sensory perception; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0006812; P:monoatomic cation transport; ISO:RGD.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0007602; P:phototransduction; ISO:RGD.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; ISO:RGD.
DR   GO; GO:0035418; P:protein localization to synapse; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0034765; P:regulation of monoatomic ion transmembrane transport; ISO:RGD.
DR   GO; GO:0150052; P:regulation of postsynapse assembly; ISO:RGD.
DR   GO; GO:0003026; P:regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback; ISO:RGD.
DR   GO; GO:0019229; P:regulation of vasoconstriction; ISO:RGD.
DR   GO; GO:0010447; P:response to acidic pH; ISO:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; ISO:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISO:RGD.
DR   GO; GO:0050915; P:sensory perception of sour taste; ISO:RGD.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006814; P:sodium ion transport; IDA:RGD.
DR   GO; GO:0007416; P:synapse assembly; ISO:RGD.
DR   Gene3D; 1.10.3590.10; acid-sensing ion channel 1 domain; 2.
DR   Gene3D; 1.10.287.820; Acid-sensing ion channel domain; 1.
DR   Gene3D; 1.10.287.770; YojJ-like; 2.
DR   InterPro; IPR001873; ENaC.
DR   InterPro; IPR004724; ENaC_chordates.
DR   InterPro; IPR020903; ENaC_CS.
DR   NCBIfam; TIGR00859; ENaC; 1.
DR   PANTHER; PTHR11690:SF128; ACID-SENSING ION CHANNEL 2; 1.
DR   PANTHER; PTHR11690; AMILORIDE-SENSITIVE SODIUM CHANNEL-RELATED; 1.
DR   Pfam; PF00858; ASC; 1.
DR   PRINTS; PR01078; AMINACHANNEL.
DR   PROSITE; PS01206; ASC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Phosphoprotein; Reference proteome;
KW   Sodium; Sodium channel; Sodium transport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..512
FT                   /note="Acid-sensing ion channel 2"
FT                   /id="PRO_0000181292"
FT   TOPO_DOM        1..37
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   TRANSMEM        38..58
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        59..427
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   TRANSMEM        428..448
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        449..512
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   SITE            478
FT                   /note="Not glycosylated"
FT   SITE            487
FT                   /note="Not glycosylated"
FT   MOD_RES         8
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         11
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        365
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   CARBOHYD        392
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   DISULFID        92..193
FT                   /evidence="ECO:0000250"
FT   DISULFID        171..178
FT                   /evidence="ECO:0000250"
FT   DISULFID        289..364
FT                   /evidence="ECO:0000250"
FT   DISULFID        307..360
FT                   /evidence="ECO:0000250"
FT   DISULFID        311..358
FT                   /evidence="ECO:0000250"
FT   DISULFID        320..342
FT                   /evidence="ECO:0000250"
FT   DISULFID        322..334
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..184
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9368048"
FT                   /id="VSP_015594"
FT   VAR_SEQ         185
FT                   /note="T -> MSRSGGARLPATALSGPGRFRMAREQPAPVAVAAARQPGGDRSGDPA
FT                   LQGPGVARRGRPSLSRTKLHGLRHMCAGRTAAGGSFQRRALWVLAFCTSLGLLLSWSSN
FT                   RLLYWLSFPSHTRVHREWSRQLPFPAVTVCNNNPLRFPRLSKGDLYYAGHWLGLLLPNR
FT                   TARPLVSELLRGDEPRRQWFRKLADFRLFLPPRHFEGISAAFMDRLGHQLEDMLLSCKY
FT                   RGELCGPHNFSS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9368048"
FT                   /id="VSP_015595"
FT   MUTAGEN         4
FT                   /note="K->N: No effect on N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   MUTAGEN         22
FT                   /note="N->S: No effect on N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   MUTAGEN         37
FT                   /note="P->N: No effect on N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   MUTAGEN         63
FT                   /note="R->N: No effect on N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   MUTAGEN         67
FT                   /note="Y->N: No effect on N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   MUTAGEN         72
FT                   /note="H->A: Inactive. Active at lower pH; when associated
FT                   with V-430."
FT                   /evidence="ECO:0000269|PubMed:11457851,
FT                   ECO:0000269|PubMed:15504740"
FT   MUTAGEN         72
FT                   /note="H->N: Increases N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:11457851,
FT                   ECO:0000269|PubMed:15504740"
FT   MUTAGEN         81
FT                   /note="A->N: Increases N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   MUTAGEN         109
FT                   /note="H->A: No effect on pH dependence and function."
FT                   /evidence="ECO:0000269|PubMed:11457851"
FT   MUTAGEN         127
FT                   /note="H->A: No effect on pH dependence and function."
FT                   /evidence="ECO:0000269|PubMed:11457851"
FT   MUTAGEN         145
FT                   /note="H->A: No effect on pH dependence and function."
FT                   /evidence="ECO:0000269|PubMed:11457851"
FT   MUTAGEN         158
FT                   /note="H->A: No effect on pH dependence and function."
FT                   /evidence="ECO:0000269|PubMed:11457851"
FT   MUTAGEN         162
FT                   /note="H->A: Loss of potentiation by Zn(2+)."
FT                   /evidence="ECO:0000269|PubMed:11457851"
FT   MUTAGEN         180
FT                   /note="H->A: No effect on pH dependence and function."
FT                   /evidence="ECO:0000269|PubMed:11457851"
FT   MUTAGEN         249
FT                   /note="H->A: No effect on pH dependence and function."
FT                   /evidence="ECO:0000269|PubMed:11457851"
FT   MUTAGEN         326
FT                   /note="H->A: No effect on pH dependence and function."
FT                   /evidence="ECO:0000269|PubMed:11457851"
FT   MUTAGEN         339
FT                   /note="H->A: Loss of potentiation by Zn(2+)."
FT                   /evidence="ECO:0000269|PubMed:11457851"
FT   MUTAGEN         365
FT                   /note="N->S: Reduces N-glycosylation. Abolishes N-
FT                   glycosylation; when associated with S-392."
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   MUTAGEN         392
FT                   /note="N->S: Reduces N-glycosylation. Abolishes N-
FT                   glycosylation; when associated with S-365."
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   MUTAGEN         414
FT                   /note="Y->N: Increases N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   MUTAGEN         423..425
FT                   /note="YEV->NES: Increases N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   MUTAGEN         430
FT                   /note="G->C: Partial activation."
FT                   /evidence="ECO:0000269|PubMed:11457851,
FT                   ECO:0000269|PubMed:8631835"
FT   MUTAGEN         430
FT                   /note="G->F: Constitutive activation causing cell death.
FT                   Inactive; when associated with F-443."
FT                   /evidence="ECO:0000269|PubMed:11457851,
FT                   ECO:0000269|PubMed:8631835"
FT   MUTAGEN         430
FT                   /note="G->K,T: Constitutive activation causing cell death."
FT                   /evidence="ECO:0000269|PubMed:11457851,
FT                   ECO:0000269|PubMed:8631835"
FT   MUTAGEN         430
FT                   /note="G->S: No constitutive activation."
FT                   /evidence="ECO:0000269|PubMed:11457851,
FT                   ECO:0000269|PubMed:8631835"
FT   MUTAGEN         430
FT                   /note="G->V: Constitutive activation causing cell death.
FT                   Activated at lower pH; when associated with A-72."
FT                   /evidence="ECO:0000269|PubMed:11457851,
FT                   ECO:0000269|PubMed:8631835"
FT   MUTAGEN         443
FT                   /note="S->F: Loss of function. Inactive; when associated
FT                   with F-430."
FT                   /evidence="ECO:0000269|PubMed:8631835"
FT   MUTAGEN         453..455
FT                   /note="YIY->NIS: No effect on N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   MUTAGEN         478
FT                   /note="N->S: No effect on N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:15504740"
FT   MUTAGEN         487
FT                   /note="N->S: No effect on N-glycosylation."
FT                   /evidence="ECO:0000269|PubMed:15504740"
SQ   SEQUENCE   512 AA;  57739 MW;  38D0A77C3C430B03 CRC64;
     MDLKESPSEG SLQPSSIQIF ANTSTLHGIR HIFVYGPLTI RRVLWAVAFV GSLGLLLVES
     SERVSYYFSY QHVTKVDEVV AQSLVFPAVT LCNLNGFRFS RLTTNDLYHA GELLALLDVN
     LQIPDPHLAD PTVLEALRQK ANFKHYKPKQ FSMLEFLHRV GHDLKDMMLY CKFKGQECGH
     QDFTTVFTKY GKCYMFNSGE DGKPLLTTVK GGTGNGLEIM LDIQQDEYLP IWGETEETTF
     EAGVKVQIHS QSEPPFIQEL GFGVAPGFQT FVATQEQRLT YLPPPWGECR SSEMGLDFFP
     VYSITACRID CETRYIVENC NCRMVHMPGD APFCTPEQHK ECAEPALGLL AEKDSNYCLC
     RTPCNLTRYN KELSMVKIPS KTSAKYLEKK FNKSEKYISE NILVLDIFFE ALNYETIEQK
     KAYEVAALLG DIGGQMGLFI GASLLTILEL FDYIYELIKE KLLDLLGKEE EEGSHDENMS
     TCDTMPNHSE TISHTVNVPL QTALGTLEEI AC
//
